122 related articles for article (PubMed ID: 23291063)
1. [Silencing effect of cell-specific RNA interference plasmid pPSMAe/p-shNS-ploy(A) loaded by transgenic vector Tf-PEG-PEI targeting nucleostemin on prostate cancer cells in vitro].
Liu RL; Wang WY; Zhang ZH; Xu Y
Zhonghua Zhong Liu Za Zhi; 2012 Oct; 34(10):725-9. PubMed ID: 23291063
[TBL] [Abstract][Full Text] [Related]
2. Cell-selective gene silencing in prostate cancer LNCap cells using prostate-specific membrane antigen promoter and enhancer in vitro and in vivo.
Liu R; Sun J; Zhang Z; Xu Y
Cell Biol Int; 2012 Oct; 36(10):863-72. PubMed ID: 22612256
[TBL] [Abstract][Full Text] [Related]
3. Tissue-selective RNA interference in prostate cancer cell using prostate specific membrane antigen promoter/enhancer.
Zhao W; Xu Y; Kong D; Liu R; Zhang Z; Jin C; Zhang Z; Xiu Y
Urol Oncol; 2009; 27(5):539-47. PubMed ID: 18639471
[TBL] [Abstract][Full Text] [Related]
4. Second-generation aptamer-conjugated PSMA-targeted delivery system for prostate cancer therapy.
Wu X; Ding B; Gao J; Wang H; Fan W; Wang X; Zhang W; Wang X; Ye L; Zhang M; Ding X; Liu J; Zhu Q; Gao S
Int J Nanomedicine; 2011; 6():1747-56. PubMed ID: 21980237
[TBL] [Abstract][Full Text] [Related]
5. New alternatively spliced variant of prostate-specific membrane antigen PSM-E suppresses the proliferation, migration and invasiveness of prostate cancer cells.
Cao KY; Xu L; Zhang DM; Zhang XM; Zhang T; He X; Wang Z; Feng FS; Qiu SP; Shen GX
Int J Oncol; 2012 Jun; 40(6):1977-85. PubMed ID: 22322627
[TBL] [Abstract][Full Text] [Related]
6. [Establishment of RNA interfering retrovirus vector targeting CXCR4 gene driven by human prostate-specific antigen promoter and its biological effects on prostate cancer cells].
Du YF; Xing YF; Zeng FQ; Lu P; Liu XY; Xiao YJ
Zhonghua Zhong Liu Za Zhi; 2007 Jul; 29(7):489-94. PubMed ID: 18069626
[TBL] [Abstract][Full Text] [Related]
7. PSMA-targeted polyinosine/polycytosine vector induces prostate tumor regression and invokes an antitumor immune response in mice.
Langut Y; Talhami A; Mamidi S; Shir A; Zigler M; Joubran S; Sagalov A; Flashner-Abramson E; Edinger N; Klein S; Levitzki A
Proc Natl Acad Sci U S A; 2017 Dec; 114(52):13655-13660. PubMed ID: 29229829
[TBL] [Abstract][Full Text] [Related]
8. Bioconjugated gold nanoparticles enhance cellular uptake: A proof of concept study for siRNA delivery in prostate cancer cells.
Guo J; O'Driscoll CM; Holmes JD; Rahme K
Int J Pharm; 2016 Jul; 509(1-2):16-27. PubMed ID: 27188645
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of nucleostemin causes G1 cell cycle arrest via a p53-independent pathway in prostate cancer PC-3 cells.
Liu R; Zhang Z; Xu Y
Urol Int; 2010; 85(2):221-7. PubMed ID: 20664182
[TBL] [Abstract][Full Text] [Related]
10. A novel regulation of PSMA and PSA expression by Q640X AR in 22Rv1 and LNCaP prostate cancer cells.
Ben Jemaa A; Sallami S; Céraline J; Oueslati R
Cell Biol Int; 2013 May; 37(5):464-70. PubMed ID: 23418075
[TBL] [Abstract][Full Text] [Related]
11. Hepatocyte-targeted psiRNA delivery mediated by galactosylated poly(ethylene glycol)-graft-polyethylenimine in vitro.
Nie C; Liu C; Chen G; Dai J; Li H; Shuai X
J Biomater Appl; 2011 Sep; 26(3):255-75. PubMed ID: 20511388
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of PEG-transferrin-PEI nanocomplex as a gene delivery agent.
Lee KM; Lee YB; Oh IJ
J Nanosci Nanotechnol; 2011 Aug; 11(8):7078-81. PubMed ID: 22103128
[TBL] [Abstract][Full Text] [Related]
13. Characterization of polyethylene glycol-polyethyleneimine as a vector for alpha-synuclein siRNA delivery to PC12 cells for Parkinson's disease.
Liu YY; Yang XY; Li Z; Liu ZL; Cheng D; Wang Y; Wen XJ; Hu JY; Liu J; Wang LM; Wang HJ
CNS Neurosci Ther; 2014 Jan; 20(1):76-85. PubMed ID: 24279586
[TBL] [Abstract][Full Text] [Related]
14. [The construction of recombinant plasmid with prostate-specific membrane antigen promoter controlling reporter gene expression].
Zeng H; Li H; Liao YC; Li X; Wu Q; Yang YR
Sichuan Da Xue Xue Bao Yi Xue Ban; 2005 Mar; 36(2):169-71. PubMed ID: 15807257
[TBL] [Abstract][Full Text] [Related]
15. [Preparation of folate-targeted magnetic nanocomposites loaded with TFPI-2 plasmid and cisplatin and evaluation of its targeting and inhibitory effect on nasopharyngeal carcinoma HNE-1 cells in vitro].
Liu RZ; Zhang J; Liu T; Fu XY; Zhang LM; Xie MQ
Zhonghua Yi Xue Za Zhi; 2016 Jul; 96(25):2023-30. PubMed ID: 27470963
[TBL] [Abstract][Full Text] [Related]
16. Specific targeting of prostate cancer cells in vitro by the suicide gene/prodrug system, uracil phosphoribosyltransferase/5-fluorouracil, under the control of prostate-specific membrane antigen promoter/enhancer.
Zhao FJ; Zhang S; Yu ZM; Xia SJ; Li H
Prostate Cancer Prostatic Dis; 2009; 12(2):166-71. PubMed ID: 18626508
[TBL] [Abstract][Full Text] [Related]
17. Prostate specific membrane antigen knockdown impairs the tumorigenicity of LNCaP prostate cancer cells by inhibiting the phosphatidylinositol 3-kinase/Akt signaling pathway.
Guo Z; Lai Y; Du T; Zhang Y; Chen J; Bi L; Lin T; Liu H; Wang W; Xu K; Jiang C; Han J; Zhang C; Dong W; Huang J; Huang H
Chin Med J (Engl); 2014; 127(5):929-36. PubMed ID: 24571890
[TBL] [Abstract][Full Text] [Related]
18. [Silencing nucleostemin expression reduces the proliferation of PC-3 cells].
Liu RL; Xu Y; Zhang ZH; Wang M; Sun JT; Zhang Y; Li SZ
Zhonghua Nan Ke Xue; 2009 Jul; 15(7):593-8. PubMed ID: 19694370
[TBL] [Abstract][Full Text] [Related]
19. Peptide GE11-Polyethylene Glycol-Polyethylenimine for targeted gene delivery in laryngeal cancer.
Ren H; Zhou L; Liu M; Lu W; Gao C
Med Oncol; 2015 Jul; 32(7):185. PubMed ID: 26008151
[TBL] [Abstract][Full Text] [Related]
20. Multifunctional drug carrier based on PEI derivatives loaded with small interfering RNA for therapy of liver cancer.
Zhao Y; Lee RJ; Liu L; Dong S; Zhang J; Zhang Y; Yao Y; Lu J; Meng Q; Xie J; Teng L
Int J Pharm; 2019 Jun; 564():214-224. PubMed ID: 31004717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
